HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: Case report and literature review

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Du, Wenjun ^a   Zheng, Zhaomin ^a   Han, Shaolei ^a   Ma, Shumin ^a   Chen, Shijun ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatitis B virus reactivation; IgM nephropathy; Occult HBV infection; Prednisone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PREDNISONE; VIRUS DNA;

AGED; ANTIGEN DETECTION; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; ECHOGRAPHY; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN M NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; LIVER INJURY; MALE; MEDICAL HISTORY; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; VIRUS REACTIVATION; VIRUS TITRATION;

EID: 84883068402     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-394     Document Type: Article

References (16)

1. Knieser MR, Jenis EH, Lowenthal DT, Bancroft WH, Burns W, Shalhoub R. Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol 1974, 97(4):193-200.
2. Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 1974, 2(7879):477-482.
3. Levy M, Gagnadoux MF. Membranous nephropathy following perinatal transmission of hepatitis B virus infection-long-term follow-up study. Pediatr Nephrol 1996, 10(1):76-78.
4. Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H. Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child 1983, 58(7):488-496. 10.1136/adc.58.7.488, 1628176, 6870328.
5. Venkataseshan VS, Lieberman K, Kim DU, et al. Hepatitis-B-associated glomerulonephritis: pathology,pathogenesis, and clinical course. Medicine (Baltimore) 1990, 69(4):200-216.
6. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alphainterferon. Kidney Int 1995, 47(1):225-230. 10.1038/ki.1995.27, 7731150.
7. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997, 92(1):3-17.
8. Fang LJ, Sheng FY, Guo YQ, et al. Hepatitis B virus associated nephritis in adults and children. ZhonghuaChuanranbingxueZazhi 1996, 14:92-95.
9. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007, 46:160-170. 10.1016/j.jhep.2006.10.007, 17112622.
10. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo C, Kay A. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 2004, 73:508-515. 10.1002/jmv.20119, 15221893.
11. Garfein RS, Bower WA, Loney CM, Hutin YJ, Xia GL, Jawanda J, Groom AV, Nainan OV, Murphy JS, Bell BP. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 2004, 40:865-873.
12. Petzold DR, Tautz B, Wolf F, Drescher J. Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially. J Med Virol 1999, 58:1-10. 10.1002/(SICI)1096-9071(199905)58:1<1::AID-JMV1>3.0.CO;2-M, 10223539.
13. Zhou XJ, Laszik Z, Nadasdy T, D'Agati VD, Silva FG. Silva's diadnostic renal pathology. Kidney International 2010, 77:939-940.
14. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991, 324:1705-1709. 10.1056/NEJM199106133242405, 2034247.
15. Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008, 148:519-528. 10.7326/0003-4819-148-7-200804010-00008, 2729097, 18378948.
16. Lai KN, Lai FM, Tam JS, Vallance-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol 1988, 29(5):229-234.